Brief: Sorrento Therapeutics, Inc. Receives Court Approval For $75 Million Financing In Chapter 11 Case
Feb 21 (Reuters) - Sorrento Therapeutics Inc SRNE.O :
* SORRENTO THERAPEUTICS, INC. RECEIVES COURT APPROVAL FOR
$75
MILLION FINANCING IN CHAPTER 11 CASE
* SORRENTO THERAPEUTICS-FINANCING WILL PROVIDE CO WITH
IMMEDIATE
LIQUIDITY SO THAT IT CAN CONTINUE OPERATING BUSINESS AS USUAL
DURING CHAPTER 11 CASE
* SORRENTO THERAPEUTICS INC - HEARING FOR FINAL APPROVAL OF
FINANCING IS CURRENTLY SET FOR MARCH 29, 2023
Source text for Eikon: ID:nPn5yMJZ3a
Further company coverage: SRNE.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sorrento Therapeutics
See all newsBrief: Scilex Holding Says US Bankruptcy Court Extended Lockup Period On Shares Of Scilex Stock
Company's PO box allows it to file for bankruptcy in Texas, judge rules
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute (updated)
Latham, Jackson Walker avoid sanctions over bankruptcy forum shopping dispute
Brief: Sorrento Therapeutics Reduced U.S. Headcount From 215 To 128 on Sept. 20